|
|
Volumn 18, Issue 8, 2012, Pages 1158-
|
|
Potential first-in-class osteoporosis drug speeds through trials
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIPHENYL DERIVATIVE;
CATHEPSIN K;
ENZYME INHIBITOR;
ODANACATIB;
CLINICAL TRIAL (TOPIC);
DRUG ANTAGONISM;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
FRACTURE;
HUMAN;
LEGAL ASPECT;
NOTE;
OSTEOPOROSIS;
UNITED STATES;
BIPHENYL COMPOUNDS;
CATHEPSIN K;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
ENZYME INHIBITORS;
FRACTURES, BONE;
HUMANS;
OSTEOPOROSIS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84867471745
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0812-1158 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|